Here are relevant reports on : continuous-glucose-monitoring-market
-
Middle East & Africa In Vitro Diagnostics Market by Product & Service (Kits, Instruments), Technology (Immunoassay, Hematology, Glucose Monitoring), Specimen (Blood), Site of Testing, Application (Endocrinology, Infectious Disease) - Forecast to 2031
The Middle East & Africa in vitro diagnostics (IVD) market, valued at USD 3.33 billion in 2025, stood at USD 3.49 billion in 2026 and is projected to advance at a resilient CAGR of 4.8% from 2026 to 2031, culminating in a forecasted valuation of USD 4.42 billion by the end of the period.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Europe Remote Patient Monitoring (RPM) Market By Offering {Software [Transmission (synchronous)], Integrated Device (Wearable, Implant, Handheld)}, Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio), End User - Forecast to 2030
Europe Remote Patient Monitoring (RPM) market, valued at US$6.16 billion in 2024, stood at US$6.87 billion in 2025 and is projected to advance at a resilient CAGR of 10.3% from 2024 to 2030, culminating in a forecasted valuation of US$11.22 billion by the end of the period.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
US Remote Patient Monitoring (RPM) Market by Offering {Software [Transmission (synchronous)], Integrated Device (Wearable, Implant, Handheld)}, Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End User - Forecast to 2030
The US Remote Patient Monitoring (RPM) Market, valued at US$14.15 billion in 2024, stood at US$16.09 billion in 2025 and is projected to advance at a resilient CAGR of 12.6% from 2025 to 2030, culminating in a forecasted valuation of US$29.13 billion by the end of the period. The US remote patient monitoring industry is driven by technological innovations in FDA-approved wearable devices, mobile health applications, and monitoring solutions.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Zero Trust Architecture Market by Solutions (IAM, Microsegmentation, ZTNA, Continuous Monitoring, Least Privilege Access), by Organization Size (SMB, Large Enterprises), by Deployment Mode (On-premise, Cloud), Vertical, and Region - Forecast to 2029
the global zero trust architecture market size is projected to reach USD 38.5 billion by 2028 at a Compound Annual Growth Rate (CAGR) of 17.3% during the forecast period. Palo Alto Networks (US), VMware (US), Zscaler (US), Akamai (US), Microsoft (US), Cisco (US), IBM (US), Citrix (US), Check Point (US), Trellix (US), Forcepoint (US), CrowdStrike (US), Cloudflare (US), Fortinet (US), Google (US), Netskope (US), Perimeter 81 (US), Twingate (US), Appgate (US), Zero Networks (Israel), Versa Networks (US), Axis Security (US), Ivanti (US), NordLayer (US), and GoodAccess (Czech Republic) are the key players and other players in the zero-trust architecture market.
- Published: November 2023
- Price: $ 4950
- TOC Available:
-
Environmental Monitoring Market by Product Type (Sensors, Indoor Monitors, Outdoor Monitors), Sampling Method (Continuous, Active, Passive, Intermittent), Component, Application, End User, and Region - Global Forecast to 2030
The global environmental monitoring market, valued at USD 15.33 billion in 2024, stood at USD 16.10 billion in 2025 and is projected to advance at a resilient CAGR of 5.6% from 2025 to 2030, culminating in a forecasted valuation of USD 21.14 billion by the end of the period. The expansion of the environmental monitoring sector is largely propelled by the imposition of stringent pollution monitoring regulations by governmental bodies, the ongoing decline in air quality characterized by escalating PM2.5 concentrations, and heightened public health concerns linked to increased pollution levels.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Patient Temperature Monitoring Market by Product (Wearable, Continuous, Digital Thermometer, Infrared Thermometer), Site (Non-invasive, Invasive), Application (Fever, Anesthesia, Hypothermia), End User (Hospital, ICU, Urgent Care) - Global Forecast to 2032
The global patient temperature monitoring market, valued at US$2.31 billion in 2024, stood at US$2.44 billion in 2025 and is projected to advance at a resilient CAGR of 6.7% from 2025 to 2032, culminating in a forecasted valuation of US$3.85 billion by the end of the period. The patient temperature monitoring market is experiencing substantial growth due to several pivotal factors. Key drivers include a burgeoning global population and an escalating incidence of infectious diseases.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Continuous Thermal Monitoring Market by Offering (Hardware, Software, Service), Application (Bus Duct Monitors, Switchgear, Motor Control Centers, Low-voltage Transformers, Dry Transformers), End User, and Region - Global Forecast to 2030
The continuous thermal monitoring market is projected to reach USD 1.49 billion by 2030, at a CAGR of 6.8% during the forecast period. The report profiles key players such as Schneider Electric (France), Siemens (Germany), ABB (Switzerland), Honeywell International Inc. (US), and Teledyne Technologies (US).
- Published: January 2025
- Price: $ 4950
- TOC Available:
-
Glucose, Dextrose, and Maltodextrin Market by Product (Glucose, Dextrose, and Maltodextrin), Application (Food & Beverages (Confectionery, Bakery, Dairy), Pharmaceuticals, Personal Care Products, Paper & Pulp), and Region - Global Forecast to 2024
The glucose, dextrose, and maltodextrin market is projected to reach USD 51.87 billion by 2024, at a CAGR of 7.0% from 2018, in terms of value. The market is driven by the increase in demand from the beverage industry, intense research & development activities, and increase in demand for convenience foods. The demand for glucose, dextrose, and maltodextrin in the food & beverages segment is expected to witness significant growth in the near future, as major food & beverage companies are expected to increase the application of glucose, dextrose, and maltodextrin due to their multiple benefits, including their role as sweeteners, binders, emulsifiers, and thickening agents. This report studies the marketing and development strategies, along with the product portfolios of leading companies such as ADM (US), Ingredion (US), AGRANA (Austria), Tate & Lyle (UK), Cargill (US), ROQUETTE (France), Grain Processing Corporation (US), Avebe Group (Netherlands), Tereos (France), Global Sweeteners Holdings (Hong Kong), Gulshan Polyols (India), and Fooding Group Limited (China).
- Published: May 2018
- Price: $ 4950
- TOC Available:
-
Continuous Manufacturing Market By Product (Integrated system, Semi-continuous (Granulator, Coater, Blender), Control), Application (API, End Product (Solid Dosage)), End User (R&D Department (CRO), Pharmaceutical Companies, CMO)- Global Forecast to 2022
The global continuous manufacturing market is projected to grow at a CAGR of 13.3%. Major players in this market include GEA Group AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bosch Packaging Technology (Germany), Coperion GmbH (Germany), and Glatt GmbH (Germany). Other players include KORSCH AG (Germany), Munson Machinery Company, Inc. (U.S.), L.B. Bohle Maschinen + Verfahren Gmbh (Germany), Gebrüder Lödige Maschinenbau GmbH (Germany), Baker Perkins Ltd. (U.K.), Scott Equipment Company (U.S.), and Sturtevant, Inc. (U.S.).
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Asia Pacific Blood Glucose Monitoring Devices Market by Product Type (Self-blood glucose monitoring, Professional point of care), Application (Diabetes management, Health & wellness Monitoring), Test Site (Fingertip, Upper arm), End User (Self/Homecare) - Forecast to 2030
The Asia Pacific blood glucose monitoring devices market, valued at USD 3.11 billion in 2024, stood at USD 3.45 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of USD 5.86 billion by the end of the period. The market is set for steady growth, driven by advancements in continuous glucose monitoring (CGM) systems and smart self-monitoring devices that enhance accuracy, enable real-time glucose data access, and improve ease of use. Rising diabetes prevalence, increasing health awareness, and the growing adoption of digital and mobile health solutions are further boosting demand for blood glucose monitoring devices across healthcare settings in the Asia Pacific region.
- Published: June 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
